Palantir (NASDAQ:PLTR) stock, like any investment, requires weighing the potential rewards against the risks. While the ...

Medpace, ICON, and West Pharma led last week's large-cap rally, driven by strong earnings beats and upgraded guidance.

Palantir stock continues to crush the broader market, but can the company sustain these gains over the next several months?

AI-native pharma disruptors like Palantir, Tempus, and Recursion are reshaping medicine. But ETFs still favor old-school giants.

Lear Corp (LEA) reports $6 billion in revenue and strategic partnerships, while navigating macroeconomic uncertainties and ...

Palantir has more than doubled in value this year as investors ramp up bets on the company’s artificial intelligence business ...

Palantir stock surged to all time high after receiving an Overweight rating and a $170 price target from Piper Sandler, ...

Piper Sandler initiated coverage of Palantir stock with an overweight rating and 170 price target, shrugging off its lofty ...

Nasdaq 100 and Dow edge higher as traders eye Fed policy and key tech earnings. AI stocks and healthcare lead US indices ...

Julie Hyman examines some of the top stories on Wall Street in Yahoo Finance's Market Minute. Palantir (PLTR) stock climbs to ...

BigBear.ai (NYSE: BBAI) has become a popular AI stock pick for investors. The stock has been incredibly volatile in 2025, but ...